Study for autosomal dominant polycystic kidney disease
Part of Genetic & congenital, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study enrolls people who have been diagnosed with autosomal dominant polycystic kidney disease (ADPKD), a genetic kidney condition that can cause kidney cysts. It aims to learn about this specific form of the disease so better care is possible for the right patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have ADPKD confirmed by at least one method (genetic test, imaging such as ultrasound/scan, or clinical/medical records).
- Your diagnosis must specifically be autosomal dominant polycystic kidney disease (ADPKD), not autosomal recessive polycystic kidney disease (ARPKD).
- You should not have ARPKD or features that suggest a different, recessive “hepato-renal fibrocystic” disease.
- If you have major birth-related (congenital) problems in other body systems, you may not qualify.
- You should not have urinary tract malformations (structural kidney/urine pathway abnormalities) that point to a different diagnosis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at people with autosomal dominant polycystic kidney disease to learn more about the condition. It is an observational study, meaning no new treatments are tested—just gathering information from your medical history and tests.
This study looks at how genetics affect the progression of kidney diseases. Joining may help researchers understand your condition better and find better treatments.
This study enrolls adults with autosomal dominant polycystic kidney disease (ADPKD) to better understand the disease and its related changes in the body. It may help researchers find improved ways to track the condition and support future treatments.
This study looks at medical records, imaging, and genetic testing for people with autosomal recessive polycystic kidney disease (ARPKD). It may help researchers better understand the condition and how it affects the liver and kidneys.
This trial is a patient registry that collects information from people who have—or might have—autosomal dominant polycystic kidney disease (ADPKD). It may help researchers better understand the condition and improve future studies.
This observational study follows people early in autosomal dominant polycystic kidney disease (ADPKD) and also some healthy volunteers to learn how the kidneys work over time. It may help researchers understand early changes, which could guide future treatments.
Hear when a new ADPKD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.